IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IMPACT Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10673
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IMPACT Therapeutics Inc (IMPACT) is a developer of therapeutics to treat cancer and other life-threatening diseases. The company provides products such as microtubule inhibitors, PARP-1 inhibitors, and Hedgehog pathway inhibitors for oncology. Its PARP-1 inhibitor is an oral bioavailability; and IMP04297 is an efficacious in several animal cancer models. The company also develops IMP3138, a small molecular microtubule inhibitor clinical candidate with advantages in vitro and in vivo over paclitaxel. It also operates oncology drug discovery and several anticancer drug development projects. IMPACT is headquartered in Nanjing, China.

IMPACT Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Impact Therapeutics Raises USD30 Million in Series C Venture Financing 10
IMPACT Therapeutics Raises USD10 Million in Series B Financing 11
IMPACT Therapeutics Raises Funds through Series A Financing 12
IMPACT Therapeutics Inc – Key Competitors 13
IMPACT Therapeutics Inc – Key Employees 14
IMPACT Therapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IMPACT Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Impact Therapeutics Raises USD30 Million in Series C Venture Financing 10
IMPACT Therapeutics Raises USD10 Million in Series B Financing 11
IMPACT Therapeutics Raises Funds through Series A Financing 12
IMPACT Therapeutics Inc, Key Competitors 13
IMPACT Therapeutics Inc, Key Employees 14

List of Figures
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LG Electronics Inc (066570):電力:M&Aディール及び事業提携情報
    Summary LG Electronics, Inc. (LG Electronics), a subsidiary of LG Corp, manufactures and markets consumer electronics and home appliances. Its product portfolio includes television, monitors, personal computers, audio and video equipment, refrigerators, washing machines, dishwashers, cooking applian …
  • Alkane Energy Plc:電力:M&Aディール及び事業提携情報
    Summary Alkane Energy Plc (Alkane Energy), a subsidiary of Basalt Infrastructure Partners LLP, is a diversified company. The company power from coal mine methane and natural gas facilities. It has natural gas, coal bed methane, coal mine methane and shale gas. Alkane Energy design, builds and operat …
  • The Carlyle Group LP (CG):企業の財務・戦略的SWOT分析
    The Carlyle Group LP (CG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Q.E.P. Co Inc (QEPC):企業の財務・戦略的SWOT分析
    Summary Q.E.P. Co Inc (QEP) is a consumer goods providing company that offers specialty tools and flooring related products. The company offers products such as adhesives, grouts and mortars, hardwood flooring, pneumatic nailers, stone and tile installation, sundries, surface protection, suspended c …
  • Ferranti Computer Systems N.V.:戦略・SWOT・企業財務分析
    Ferranti Computer Systems N.V. - Strategy, SWOT and Corporate Finance Report Summary Ferranti Computer Systems N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gestamp Renewable Industries:電力:M&Aディール及び事業提携情報
    Summary Gestamp Renewable Industries, a subsidiary of Corporacion Gestamp SL, is a renewable energy service provider. The company offers development, promotion, construction and operation of electric generation power plants from biomass. It offers production, logistics, packaging, generation, design …
  • Clovis Oncology Inc (CLVS)-医療機器分野:企業M&A・提携分析
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Nichi-Iko Pharmaceutical Co Ltd (4541):企業の財務・戦略的SWOT分析
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahis …
  • BPCE SA:企業のM&A・事業提携・投資動向
    BPCE SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPCE SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Liquor Control Board of Ontario:企業の戦略的SWOT分析
    Liquor Control Board of Ontario - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Repros Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Smith & Williamson Holdings Ltd:企業の戦略的SWOT分析
    Smith & Williamson Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bionure Farma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases that concentrates on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment such as optic neuritis and neuromyelitis optica. Its lead ca …
  • 3M Company:戦略・SWOT・企業財務分析
    3M Company - Strategy, SWOT and Corporate Finance Report Summary 3M Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sevion Therapeutics Inc (SVON)-製薬・医療分野:企業M&A・提携分析
    Summary Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic …
  • The Kraft Heinz Co:企業の戦略・SWOT・財務情報
    The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report Summary The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ardena Holding NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Ardena Holding NV (Ardena) is a contract development and manufacturing organization. The company offers solid-state chemistry services including polymorph, salt, and co-crystal screening; bio-analytical and formulation development; early-phase clinical supply manufacturing; clinical logistic …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆